Functional Neuroimaging in PTSD: From Discovery of Underlying Mechanisms to Addressing Diagnostic Heterogeneity
Despite extensive research, available psychotherapics and pharmacotherapies for posttraumatic stress disorder (PTSD) have shown only limited benefits. The cause of limited treatment efficacy in PTSD may lie not only in the treatments themselves but in the heterogeneity within the diagnosis of PTSD....
Saved in:
Published in | The American journal of psychiatry Vol. 178; no. 2; pp. 128 - 135 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
United States
American Psychiatric Association
01.02.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Despite extensive research, available psychotherapics and pharmacotherapies for posttraumatic stress disorder (PTSD) have shown only limited benefits. The cause of limited treatment efficacy in PTSD may lie not only in the treatments themselves but in the heterogeneity within the diagnosis of PTSD. PTSD is currently defined by exposure to a wide variety of traumatic events and by a broad constellation of physical, affective, behavioral, and cognitive symptoms. Improving the diagnostic specificity of PTSD would yield more homogeneous patient samples and increase the likelihood of identifying clinically meaningful neurobiological markers, which could in turn serve as objective. measurable targets for novel and specific treatments. In trying to address the problem, functional neuroimaging studies have become central to efforts to characterize neural markers of PTSD. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ISSN: | 0002-953X 1535-7228 |
DOI: | 10.1176/appi.ajp.2020.20121727 |